Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription - PubMed (original) (raw)
Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription
D Braaten et al. J Virol. 1996 Jun.
Abstract
Cyclophilin A (CyPA) is incorporated into human immunodeficiency virus type 1 (HIV-1) virions via contact with the Gag polyprotein. Genetic or pharmacologic disruption of CyPA incorporation causes a quantitative reduction in virion infectivity with no discernible effects on virion assembly or on endogenous reverse transcriptase activity. Instead, the reduction of virion-associated CyPA is accompanied by a parallel, quantitative decrease in the initiation of viral DNA synthesis after infection of T cells. The infectivity of CyPA-deficient virions is not restored by pseudotyping with Env of amphotropic murine leukemia virus, demonstrating that CyPA is not required for the HIV-1-Env-CD4 interaction. These results indicate that CyPA is required for an early step in the HIV-1 life cycle following receptor binding and membrane fusion but preceding reverse transcription. CyPA is the first cellular protein other than the cell surface receptor shown to be required for an early event in the life cycle of a retrovirus.
Similar articles
- The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein.
Braaten D, Ansari H, Luban J. Braaten D, et al. J Virol. 1997 Mar;71(3):2107-13. doi: 10.1128/JVI.71.3.2107-2113.1997. J Virol. 1997. PMID: 9032343 Free PMC article. - Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization.
Colgan J, Yuan HE, Franke EK, Luban J. Colgan J, et al. J Virol. 1996 Jul;70(7):4299-310. doi: 10.1128/JVI.70.7.4299-4310.1996. J Virol. 1996. PMID: 8676452 Free PMC article. - Human immunodeficiency virus type 1 hijacks host cyclophilin A for its attachment to target cells.
Saphire AC, Bobardt MD, Gallay PA. Saphire AC, et al. Immunol Res. 2000;21(2-3):211-7. doi: 10.1385/IR:21:2-3:211. Immunol Res. 2000. PMID: 10852119 Review. - HIV-1 gag proteins: diverse functions in the virus life cycle.
Freed EO. Freed EO. Virology. 1998 Nov 10;251(1):1-15. doi: 10.1006/viro.1998.9398. Virology. 1998. PMID: 9813197 Review.
Cited by
- Cell Type-Dependent Escape of Capsid Inhibitors by Simian Immunodeficiency Virus SIVcpz.
Twizerimana AP, Scheck R, Becker D, Zhang Z, Wammers M, Avelar L, Pflieger M, Häussinger D, Kurz T, Gohlke H, Münk C. Twizerimana AP, et al. J Virol. 2020 Nov 9;94(23):e01338-20. doi: 10.1128/JVI.01338-20. Print 2020 Nov 9. J Virol. 2020. PMID: 32907979 Free PMC article. - Cyclophilin A-dependent restriction to capsid N121K mutant human immunodeficiency virus type 1 in a broad range of cell lines.
Takemura T, Kawamata M, Urabe M, Murakami T. Takemura T, et al. J Virol. 2013 Apr;87(7):4086-90. doi: 10.1128/JVI.01319-12. Epub 2013 Jan 16. J Virol. 2013. PMID: 23325683 Free PMC article. - Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1.
Martinez-Picado J, Prado JG, Fry EE, Pfafferott K, Leslie A, Chetty S, Thobakgale C, Honeyborne I, Crawford H, Matthews P, Pillay T, Rousseau C, Mullins JI, Brander C, Walker BD, Stuart DI, Kiepiela P, Goulder P. Martinez-Picado J, et al. J Virol. 2006 Apr;80(7):3617-23. doi: 10.1128/JVI.80.7.3617-3623.2006. J Virol. 2006. PMID: 16537629 Free PMC article. - Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cells.
Norris PJ, Moffett HF, Brander C, Allen TM, O'Sullivan KM, Cosimi LA, Kaufmann DE, Walker BD, Rosenberg ES. Norris PJ, et al. AIDS Res Hum Retroviruses. 2004 Mar;20(3):315-25. doi: 10.1089/088922204322996554. AIDS Res Hum Retroviruses. 2004. PMID: 15117455 Free PMC article. - Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles.
Cartier C, Deckert M, Grangeasse C, Trauger R, Jensen F, Bernard A, Cozzone A, Desgranges C, Boyer V. Cartier C, et al. J Virol. 1997 Jun;71(6):4832-7. doi: 10.1128/JVI.71.6.4832-4837.1997. J Virol. 1997. PMID: 9151881 Free PMC article.
References
- Nature. 1993 Oct 14;365(6447):666-9 - PubMed
- Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8351-5 - PubMed
- Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5381-5 - PubMed
- J Virol. 1993 Nov;67(11):6542-50 - PubMed
- J Virol. 1990 Oct;64(10):5076-92 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials